GLI GLI Quality Tool
GLI Quality Tool — Version 2.0

Writing a Reliable TB Laboratory Equipment Acceptance Protocol

New equipment should never move directly from delivery to patient testing. A centrifuge, biosafety cabinet, molecular platform, refrigerator, autoclave, or pipette needs documented evidence that it is safe, correctly installed, fit for its intended use, and suitable for the laboratory’s workflow. Acceptance testing creates that evidence before routine results depend on the instrument.

For tuberculosis laboratories, the protocol must address more than whether the power comes on. Equipment may support culture, microscopy, nucleic acid amplification, antimicrobial susceptibility testing, specimen processing, or decontamination. Each use brings different risks involving infectious material, aerosols, contamination, temperature control, software, calibration, and result interpretation.

A practical protocol should be clear enough for a metropolitan laboratory in Melbourne or Sydney and adaptable enough for a regional or remote service. It should align with the laboratory’s quality management system, manufacturer instructions, local workplace safety requirements, and the evidence expected during an assessment.

Define The Equipment And Its Intended Use

Begin with an equipment identification section. Record the manufacturer, model, serial number, asset number, supplier, purchase order, delivery date, location, software version, accessories, and warranty details. State whether the item is new, refurbished, relocated, or being introduced after a major upgrade. Attach the quotation, technical specifications, user manual, installation requirements, and service agreement where relevant.

The intended use should be written in operational terms. For example, “used for nucleic acid extraction from decontaminated sputum specimens” is more useful than “used for molecular testing.” Identify the test method, specimen type, expected workload, authorised users, containment level, and any connected instruments or information systems.

Include a risk-based justification for the acceptance activities. A laboratory centrifuge used for infectious specimens may require checks for lid locking, rotor integrity, balance detection, speed, temperature, and aerosol containment. A refrigerator used for reagents may require mapping at different loads and seasonal conditions. A pipette used for critical reagent preparation may need gravimetric verification and a defined tolerance.

The protocol should name who is responsible for approval. This can include the laboratory manager, senior scientist, biomedical engineer, infection prevention representative, information technology staff, and supplier technician. In Australia, responsibilities may cross state or territory health services, so the sign-off pathway should be agreed before delivery rather than reconstructed after installation.

Set Installation And Safety Requirements

Acceptance testing starts with the installation environment. Document the required bench strength, floor clearance, ventilation, temperature, humidity, water supply, drainage, gas supply, network access, uninterruptible power, and electrical capacity. Australia’s 230–240 V, 50 Hz supply and local plug and circuit arrangements should match the manufacturer’s specifications. Equipment intended for another market may require an approved electrical solution before it is connected.

For biosafety cabinets, autoclaves, extraction systems, and other safety-critical equipment, define installation and performance checks separately. A cabinet may require airflow, alarm, filter, sash, and electrical testing. An autoclave may require temperature and pressure verification, cycle review, safety-valve checks, and load-specific performance evidence. The protocol should state which checks are performed by laboratory staff and which require a competent external technician.

Consider the local service environment. A supplier in Perth may provide different response times from one supporting a laboratory in regional Queensland or the Northern Territory. Record escalation contacts, spare-parts availability, remote support arrangements, preventative maintenance intervals, and expected downtime. If the instrument is essential to tuberculosis diagnosis, document the contingency method, referral laboratory, specimen transport conditions, and communication process.

Before testing begins, confirm that staff have received appropriate training and that the work area is ready. Training records should identify the trainer, date, attendees, topics, competency method, and any restrictions on use. A staff member may be shown how to operate a platform without being authorised to release results, troubleshoot faults, or change validated settings.

Build A Testable Acceptance Plan

Every acceptance test should have a measurable requirement, a method, an acceptance limit, a result, and an assessor’s signature or electronic approval. Avoid vague statements such as “equipment working correctly.” Replace them with criteria such as “temperature remains between 2 °C and 8 °C for the defined monitoring period” or “all required safety alarms activate and are recorded.”

Use manufacturer specifications, the purchase contract, regulatory requirements, risk assessment, and the intended test method to set limits. Where a supplier provides a factory acceptance certificate, treat it as supporting evidence rather than a substitute for checking the equipment in its actual laboratory environment. A platform can pass factory testing and still fail because of voltage variation, room temperature, network restrictions, loading patterns, or operator practice.

A useful protocol separates physical, functional, analytical, and workflow testing. Physical testing confirms condition and completeness. Functional testing examines controls, alarms, movement, heating, cooling, timing, and software. Analytical testing uses appropriate materials to assess precision, accuracy, carryover, contamination, or agreement with an established method. Workflow testing confirms that the instrument can be used safely from specimen receipt through result transmission and record retention.

Test area Evidence to collect Typical acceptance decision
Delivery and installation Asset details, condition report, installation certificate Complete, undamaged, correctly located
Safety and environment Electrical, airflow, alarm, temperature, and access checks All safety controls operate within limits
Function and software Startup, shutdown, error handling, user access, version records Required functions operate and settings are controlled
Analytical performance Controls, reference materials, precision or comparison results Results meet predefined laboratory criteria
Connectivity and workflow Interface messages, audit trail, barcode, report routing Data move correctly without unauthorised changes
Training and maintenance Competency records, service plan, job aids Staff are authorised and support is available

For molecular TB platforms, include contamination control and internal process controls where appropriate. For culture-related equipment, consider temperature stability, incubation conditions, contamination prevention, and access logs. The protocol should identify the number of runs, specimens or control materials required, who reviews the data, and what happens when a test fails.

Manage Failures And Change Control

Acceptance testing is useful only when failed results trigger a controlled response. Define categories such as critical failure, major deviation, minor deviation, and observation. A failed biosafety alarm or incorrect incubation temperature should normally prevent release for use. A missing label may be corrected before commissioning but still requires documentation.

Record the problem, date, equipment identification, test affected, observed result, expected result, immediate containment, person notified, supplier response, corrective action, and retest outcome. The laboratory’s incident process should connect with its quality management system; a practical corrective action form can help standardise this record when equipment problems create a quality or safety event.

Do not allow informal changes during testing. Altered software settings, replacement components, revised extraction volumes, or a new connection to the laboratory information system may change the risk profile. Document each change, assess its effect, repeat affected tests, and obtain approval before the equipment is released.

If acceptance cannot be completed immediately, label the equipment clearly as unavailable, restricted, or under evaluation. Store specimens and reagents using an approved alternative process. The protocol should prevent accidental use by staff who were not involved in the testing, especially during busy periods or when a new analyser has been placed beside an existing one.

Approve Commissioning And Ongoing Review

The final section should provide a commissioning decision: accepted for routine use, accepted with restrictions, rejected pending corrective action, or returned to the supplier. List all unresolved issues, their owners, due dates, and interim controls. The approval should be signed by the designated laboratory authority and retained with the equipment record.

A commissioning pack may include the completed protocol, delivery documents, installation and calibration certificates, test results, software and configuration records, training evidence, risk assessment, service contract, maintenance schedule, and final approval. Store it where authorised staff can retrieve it, with version control and protection against unauthorised alteration.

The quality system should also define post-acceptance review. Check performance after an agreed period, after relocation, after major repair, after software updates, and when recurring faults appear. Trend failed controls, downtime, service visits, temperature excursions, and user-reported problems. These data can show that equipment passed initial acceptance but is no longer performing reliably.

For laboratories using the GLI Quality Tool, acceptance testing can be connected to the broader quality management roadmap. The Phase 1 guidance is particularly useful when establishing foundational controls for documents, equipment, personnel, safety, and responsibilities. This approach helps ensure that the protocol becomes part of normal laboratory practice rather than a one-off purchasing document.

A strong protocol protects staff, specimens, patients, and the laboratory’s accreditation status. It also gives suppliers clear expectations and creates an auditable basis for deciding whether equipment is ready for service. Before the next instrument is switched on for clinical work, adapt the protocol to its risks, complete every defined test, resolve deviations, and obtain documented authorisation for commissioning.